Cargando…
Loss of Ercc1 Results in a Time- and Dose-Dependent Reduction of Proliferating Early Hematopoietic Progenitors
The endonuclease complex Ercc1/Xpf is involved in interstrand crosslink repair and functions downstream of the Fanconi pathway. Loss of Ercc1 causes hematopoietic defects similar to those seen in Fanconi Anemia. Ercc1 (−/−) mice die 3-4 weeks after birth, which prevents long-term follow up of the he...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371671/ https://www.ncbi.nlm.nih.gov/pubmed/22701168 http://dx.doi.org/10.1155/2012/783068 |
_version_ | 1782235235281272832 |
---|---|
author | Verhagen-Oldenampsen, Judith H. E. Haanstra, Jurgen R. van Strien, Paulina M. H. Valkhof, Marijke Touw, Ivo P. von Lindern, Marieke |
author_facet | Verhagen-Oldenampsen, Judith H. E. Haanstra, Jurgen R. van Strien, Paulina M. H. Valkhof, Marijke Touw, Ivo P. von Lindern, Marieke |
author_sort | Verhagen-Oldenampsen, Judith H. E. |
collection | PubMed |
description | The endonuclease complex Ercc1/Xpf is involved in interstrand crosslink repair and functions downstream of the Fanconi pathway. Loss of Ercc1 causes hematopoietic defects similar to those seen in Fanconi Anemia. Ercc1 (−/−) mice die 3-4 weeks after birth, which prevents long-term follow up of the hematopoietic compartment. We used alternative Ercc1 mouse models to examine the effect of low or absent Ercc1 activity on hematopoiesis. Tie2-Cre-driven deletion of a floxed Ercc1 allele was efficient (>80%) in fetal liver hematopoietic cells. Hematopoietic stem and progenitor cells (HSPCs) with a deleted allele were maintained in mice up to 1 year of age when harboring a wt allele, but were progressively outcompeted when the deleted allele was combined with a knockout allele. Mice with a minimal Ercc1 activity expressed by 1 or 2 hypomorphic Ercc1 alleles have an extended life expectancy, which allows analysis of HSPCs at 10 and 20 weeks of age. The HSPC compartment was affected in all Ercc1-deficient models. Actively proliferating multipotent progenitors were most affected as were myeloid and erythroid clonogenic progenitors. In conclusion, lack of Ercc1 results in a severe competitive disadvantage of HSPCs and is most deleterious in proliferating progenitor cells. |
format | Online Article Text |
id | pubmed-3371671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-33716712012-06-13 Loss of Ercc1 Results in a Time- and Dose-Dependent Reduction of Proliferating Early Hematopoietic Progenitors Verhagen-Oldenampsen, Judith H. E. Haanstra, Jurgen R. van Strien, Paulina M. H. Valkhof, Marijke Touw, Ivo P. von Lindern, Marieke Anemia Research Article The endonuclease complex Ercc1/Xpf is involved in interstrand crosslink repair and functions downstream of the Fanconi pathway. Loss of Ercc1 causes hematopoietic defects similar to those seen in Fanconi Anemia. Ercc1 (−/−) mice die 3-4 weeks after birth, which prevents long-term follow up of the hematopoietic compartment. We used alternative Ercc1 mouse models to examine the effect of low or absent Ercc1 activity on hematopoiesis. Tie2-Cre-driven deletion of a floxed Ercc1 allele was efficient (>80%) in fetal liver hematopoietic cells. Hematopoietic stem and progenitor cells (HSPCs) with a deleted allele were maintained in mice up to 1 year of age when harboring a wt allele, but were progressively outcompeted when the deleted allele was combined with a knockout allele. Mice with a minimal Ercc1 activity expressed by 1 or 2 hypomorphic Ercc1 alleles have an extended life expectancy, which allows analysis of HSPCs at 10 and 20 weeks of age. The HSPC compartment was affected in all Ercc1-deficient models. Actively proliferating multipotent progenitors were most affected as were myeloid and erythroid clonogenic progenitors. In conclusion, lack of Ercc1 results in a severe competitive disadvantage of HSPCs and is most deleterious in proliferating progenitor cells. Hindawi Publishing Corporation 2012 2012-06-03 /pmc/articles/PMC3371671/ /pubmed/22701168 http://dx.doi.org/10.1155/2012/783068 Text en Copyright © 2012 Judith H. E. Verhagen-Oldenampsen et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Verhagen-Oldenampsen, Judith H. E. Haanstra, Jurgen R. van Strien, Paulina M. H. Valkhof, Marijke Touw, Ivo P. von Lindern, Marieke Loss of Ercc1 Results in a Time- and Dose-Dependent Reduction of Proliferating Early Hematopoietic Progenitors |
title | Loss of Ercc1 Results in a Time- and Dose-Dependent Reduction of Proliferating Early Hematopoietic Progenitors |
title_full | Loss of Ercc1 Results in a Time- and Dose-Dependent Reduction of Proliferating Early Hematopoietic Progenitors |
title_fullStr | Loss of Ercc1 Results in a Time- and Dose-Dependent Reduction of Proliferating Early Hematopoietic Progenitors |
title_full_unstemmed | Loss of Ercc1 Results in a Time- and Dose-Dependent Reduction of Proliferating Early Hematopoietic Progenitors |
title_short | Loss of Ercc1 Results in a Time- and Dose-Dependent Reduction of Proliferating Early Hematopoietic Progenitors |
title_sort | loss of ercc1 results in a time- and dose-dependent reduction of proliferating early hematopoietic progenitors |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371671/ https://www.ncbi.nlm.nih.gov/pubmed/22701168 http://dx.doi.org/10.1155/2012/783068 |
work_keys_str_mv | AT verhagenoldenampsenjudithhe lossofercc1resultsinatimeanddosedependentreductionofproliferatingearlyhematopoieticprogenitors AT haanstrajurgenr lossofercc1resultsinatimeanddosedependentreductionofproliferatingearlyhematopoieticprogenitors AT vanstrienpaulinamh lossofercc1resultsinatimeanddosedependentreductionofproliferatingearlyhematopoieticprogenitors AT valkhofmarijke lossofercc1resultsinatimeanddosedependentreductionofproliferatingearlyhematopoieticprogenitors AT touwivop lossofercc1resultsinatimeanddosedependentreductionofproliferatingearlyhematopoieticprogenitors AT vonlindernmarieke lossofercc1resultsinatimeanddosedependentreductionofproliferatingearlyhematopoieticprogenitors |